| |
Giant Cell Tumor |
|
Clinical Futures |
| |
-
5%
of primary bone tumor and 20% of benign bone tumor;
-
Age: 30-40, slightly F>M;
-
Sites: the ends (epiphyses) of long bones. Most common sites,
distal femur > proximal tibia (totally 46%) >distal end of
radius;
-
Most common symptom, pain. Rare pathologic fracture;
|
|
Radiology Findings |
| |
-
Eccentric, well-demarcated, purely lytic lesion in the end of
long bone;
-
>50% involve the articular cartilage;
-
Soft tissue extension and formation of eggshell new bone;
-
Not often sclerosis.
|
|
Gross Findings |
| |
-
Eccentric at the end of long bone;
-
Large or small cystic areas. Thinned cortex, extension to the
soft tissue with eggshell new bone;
-
Soft tumor, typically dark brown, may have yellow discoloration.
|
|
Microscopic Findings |
| |
-
Mononuclear cells and giant cells, typically arranged in a
compact fashion, no collagen formation;
-
Mononuclear cells: round/oval nuclei with uniformly distributed
chromatin and indistinct nucleoli; mitosis always present, but
never atypical; amphophilic to eosinophilic cytoplasm with
indistinct borders, may appear vacuolated;
-
Giant cells: multinucleated, 40-60; nuclear features similar to
mononuclear cells;
-
Mononuclear cells may be spindle and arranged in a storiform
pattern;
-
frequent clusters of foam cells;
-
Secondary aneurysmal bone cyst, not uncommon;
-
Reactive bone formation;
-
Areas of infarct-like necrosis, common.
|
|
Differential Diagnosis |
| |
-
Aneurysmal bone cyst: skeletally immature patients;
predominantly metaphyseal; spindled mononuclear cells;
produce collagen;
-
Metaphyseal fibrous defect
-
Chondroblast
-
Osteosarcoma with giant cells
|
|
Immunohistochemistry Straining |
| |
-
Over expression of c-myc, strong association with metastasis;
-
u-PA, u-PAR, PAI-1, higher aggressiveness.
|
|
Election Microscopy |
| |
|
|
Cytogenetics |
| |
|
|
Treatment and Prognosis |
| |
-
Curettage
-
Recurrence, 25-50%
-
Rarely metastasis, <3%
|
|
Reference |
| |
|